Below you will find a list of the institutions who made up the Prevention Standards Partnership during the EDPQS Phase II project (in alphabetical order by country). Further details about individual institutions can be viewed by clicking on the name of the institution or by scrolling down on this page.
The picture shows the second meeting of the Prevention Standards Partnership during Phase II of the project, hosted by ASL Milano in Italy, February 2014. (click on the image to enlarge it)
Back row from left: Renzo Balugani, ASL 2 Savonese, Italy; Maurizio Panza, ASL 2 Savonese, Italy; Corrado Celata, ASL Milano, Italy; Piotr Oniszk, MCPS, Poland; Edit Sebestyén, Eötvös Loránd University, Hungary; Angelina Brotherhood, LJMU, UK; Harry Sumnall, LJMU, UK; Anders Eriksson, Social Services Administration, Stockholm, Sweden; Roland Lehner, Institut Suchtprävention, pro mente Oberösterreich, Austria; Anders Tengström, Karolinska Institute, Sweden; Franz Gschwandtner, Institut Suchtprävention, pro mente Oberösterreich, Austria; Jeff Lee, LJMU, UK.
Front row from left: Artur Malczewski, NBDP, Poland; Maria Wrońska, MCPS, Poland; Simona Olivadoti, ASL Milano, Italy; Nadia Vimercati, ASL Milano, Italy; Veronika Pavlas Martanová, CUNI, Czech Republic; Carine Mutatayi, OFDT, France; Ioulia Bafi, UMHRI, Greece; Rachele Donini, ASL 2 Savonese, Italy; Anna Zunino, ASL 2 Savonese, Italy.
Project partners (co-beneficiaries)
Institut Suchtprävention, pro mente Oberösterreich, Austria
Charles University Prague (CUNI), Czech Republic
Observatoire français des drogues et des toxicomanies (OFDT), France
University Mental Health Research Institute (UMHRI), Greece
Eötvös Loránd University, Hungary
Azienda Sanitaria Locale Milano (ASL Milano), Italy
Azienda Sanitaria Locale 2 – Savonese (ASL 2 Savonese), Italy
Mazowieckie Centrum Polityki Społecznej (MCPS), Poland
United Nations Office on Drugs and Crime (UNODC)
Gesundheit Österreich GmbH, Austria
University Hospital Heidelberg (REBOUND), Germany
National Bureau for Drug Prevention (NBDP), Poland
Delegacion del Gobierno para el Plan Nacional sobre Drogas, Spain
Social Development Unit, Social Services Administration, Stockholm, Sweden
Web site: http://www.cph.org.uk
The organisation: The Centre for Public Health (CPH) within Liverpool John Moores University is responsible for the European Drug Prevention Quality Standards (EDPQS) project. The Centre specialises in applied research and educational programmes addressing health issues at all levels from policy development to service delivery. CPH is committed to a multi-disciplinary approach to public health and works in partnership with health services, local authorities, judicial bodies, environmental services and community groups. Influencing health service design and delivery, as well as health-related policy, the Centre for Public Health’s research has been at the forefront of the development of multi-agency strategies to promote and protect public health. The Centre is a World Health Organization (WHO) Collaborating Centre for Violence Prevention. As a Collaborating Centre it works with WHO to support work on the prevention of violence on an international basis; cooperating with other countries to reduce both the levels of violence they experience and the impacts such violence has on people’s health.
The Phase II project team at the Centre for Public Health
Principal Investigator for Phase II: Harry Sumnall is a Professor in Substance Use at the Centre for Public Health. He is interested in all aspects of substance use, particularly young people’s health issues. Harry’s funded research programmes have examined the evidence base for substance misuse prevention and the mechanisms for implementing evidence based practice and policy. Harry also has research interests in psychopharmacology and addictive behaviours, with a focus upon causes, consequences, and experiences of drug use. He is also interested in the psychopharmacology of entactogens and hallucinogens and the developing field of new psychoactive substances (legal highs). Harry is a member of the UK Advisory Council on the Misuse of Drugs, and Past President of the European Society for Prevention Research.
Project Manager for Phase II: Jeff Lee was the Project Manager for the European Drug Prevention Quality Standards (EDPQS) Phase II initiative. His main role was to coordinate and support the work of the European partners in the project. Jeff previously worked as Executive Director of Mentor International, a substance abuse prevention focused international NGO and before that as the Director of the Advisory Council for Alcohol and Drug Education, a national NGO based in Manchester. Initially a teacher, Jeff’s focus has always been to promote the role of health and education in preventing drug misuse among young people within the context of promoting health and well-being. He has undertaken a range of project management work around the world and developed a particular reputation for his training and resource development in the field of life skills education. Jeff has worked in more than 80 countries which included consultancy work for governments, the EU, WHO and UNODC. He also has a commitment to helping transfer the work of science, research and academia to become relevant and accessible to the practitioner and policy-maker.
Angelina Brotherhood was a Consultant for the Centre for Public Health during the EDPQS Phase II project. Whilst at the Centre, she worked predominantly on international research projects to inform European drugs policy and practice. Angelina authored the European Drug Prevention Quality Standards in Phase I and supported the development of the International Standards on Drug Use Prevention published by the United Nations Office on Drugs and Crime (UNODC). In Phase II, her role included developing the project methodology and synthesising findings across the Partnership. Her research interests lie across the fields of substance use and urban studies.
Amanda Atkinson is a Senior Researcher within the Centre for Public Health. Amanda has worked on a range of research projects within the Centre, predominantly relating to young people, drinking cultures, alcohol and drug-related violence, and substance use. She has a particular interest in media representations of substance use and is currently writing in this area. Amanda has led projects such as a Joseph Rowntree Foundation funded project exploring the influence of media representations of alcohol on young people’s drinking and the European School Survey on Alcohol and other Drugs (ESPAD). She has experience of both qualitative and quantitative methods and has conducted research with a range of groups, including children and young people, substance users, prisoners, victims of domestic violence, young offenders, practitioners and media professionals. Her general research interests relate to youth leisure and health, gender, substance use and media representations of these issues.
Role in the Phase II project: As in Phase I, LJMU was the overall project lead, responsible for coordinating the work and managing the Partnership. As such, it also hosted the project kick-off meeting in Liverpool in April 2013. LJMU participated actively in all activities throughout the project and had responsibility for synthesising project findings across partners. LJMU also developed toolkits in collaboration with other partners (EDPQS Toolkit 3 and Toolkit 4 working groups). LJMU was also in charge of the project website.
Project partners (co-beneficiaries)
Institut Suchtprävention, pro mente Oberösterreich, Austria
Web site: http://www.praevention.at/
The organisation: The “Institute for the Prevention of Addictions and Drug Abuse” was founded in 1994 as part of pro mente Upper Austria in Linz. It is nearly entirely financed by the Upper Austrian Federal Government. For single projects the aid money is donated by the European Union, the Austrian Federal Ministry for Health, the Austrian Federal Ministry for Education and Culture, the Foundation “Gesundes Österreich” (Healthy Austria), and by co-operations with single persons. Our team consists of 30 members. Their varied education and functions resemble the different target groups and meet their needs. Psychotherapists and continuing adult education trainers are as well members of the institute as are pedagogues, psychologists and communication scientists, sociologists, social scientists and social workers. They all emphasise our interdisciplinary character.
In order to achieve these goals, the prevention of addiction also needs to be seriously defined as a principle of action on the political level. This principle must be applied likewise in all socially relevant areas – particularly in the domains of business, social matters, health, family and safety.
What we do…
The Phase II project team at the Institut Suchtprävention
Franz Gschwandtner was the Phase II project lead for the Institute for the Prevention of Addictions and Drug Abuse and a member of the research and evaluation department.
Roland Lehner, a member of the research and evaluation department.
Key contact for Phase II: Franz Gschwandtner is a sociologist and has been working since 2002 in the research and evaluation department of the Institute for the Prevention of Addictions and Drug Abuse.
Role in the Phase II project: A new partner in Phase II, the Institut Suchtprävention participated in a number of project activities, including conducting a case study of a prevention project (Peer Drive Clean) in Upper Austria, mapping and reviewing existing prevention and health promotion toolkits, carrying out an assessment of local professional needs, and developing toolkits in collaboration with the other partners (EDPQS Toolkit 2 working group).
Web site: http://www.adiktologie.cz/
The organisation: The Department of Addictology is a scientific and clinical workplace of the First Faculty of Medicine, Charles University in Prague and General Faculty Hospital in Prague. It was established on January 1st 2012, combining the Centre for Addictology of the Psychiatric Clinic, First Faculty of Medicine, Charles University in Prague and General Faculty Hospital in Prague and Unit for Addiction Treatment of the General Faculty Hospital in Prague. The department represents a unique merger of two separate workplaces that involve both clinical and paramedical professions that are involved in the recently established field of addictology.
The Phase II project team at Charles University Prague
Key contact for Phase II: Roman Gabrhelík, Ph.D. was the Phase II project lead at the Czech partner institution. Roman is Head of the Centre for Prevention at the Department of Addictology. Roman’s current focus is on prevention of substance abuse (and other risk behaviours); and treatment (pharmacotherapy of methamphetamine users, use of novel technology in data collection and treatment). Roman serves as en executive editor of the journal Adiktologie [Addictology].
Veronika Pavlas Martanová Ph.D. Veronika’s general activities include:
Helena Pacnerová, D.Phil. is active in the Agency of certification of primary prevention programs. Her work includes research in prevention of risk behaviour of children in institutional care, development of assessment methods, cooperation with the Ministry of Education, development of standards for primary prevention programmes, coordination and evaluation of the certification process in primary prevention. She is Head of the psychological section of the Institute.
Role in the Phase II project: A new partner in Phase II, CUNI led the review of existing indicators in prevention and health promotion during the first year of the project. CUNI also implemented a pilot training workshop with prevention professionals (certifiers) in the Czech Republic to test EDPQS Toolkit 3.
Web site: http://www.ofdt.fr/
The organisation: The OFDT (Observatoire Français des Drogues et des Toxicomanies, French Monitoring Centre for Drugs and Drug Addiction) is legally constituted as an independent and non-profit public institute and is endowed with a scientific mission. Since its foundation in 1997, its general goals have been to gather, to analyse and to disseminate reliable data on the drug phenomenon and the related public responses in France. Its scope of work, originally focused on illicit drugs, has widened to legal drugs – such as alcohol, tobacco and psychotropic medicines – since 1999 and more recently to gaming and gambling issues. Alongside its national mission, OFDT provides relevant information to meet the requirements of the REITOX European Network of information on Drugs, established by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
The ODFT has been involved in data collection, studies and exchange networks, on illicit and licit drugs, implementing or contributing to national surveys in general and special populations (like ESPAD or HBSC) and on specific areas or user groups (treatment or low-threshold services, recreational settings). OFDT also has an expertise in the identification and monitoring of emerging trends regarding substances and patterns of use, especially synthetic drugs. A specific staff is dedicated to evaluation studies on public responses (whether national policies or experimental services) and supports the promotion of good practices in drug demand reduction.
The OFDT comprises over 30 permanent staff with skills in statistics, demography, economics, epidemiology, medicine, pharmacy, sociology, political sciences and evaluation. Its Management Board brings together representatives from the main departments concerned with drug policies and non-governmental qualified professionals as well. An independent scientific committee provides advice to OFDT on its work programme and reviews its productions.
Over the last 15 years, the OFDT has been involved in several international projects through the coordination of or the contribution to EC granted projects (I-Trend in 2013-2015, ALICE RAP over 2011-2016, ERANID over 2013-2016, EDPQS over 2013-2015, Trend-Europe in 2003-2004), expertise in the framework of twinning programmes (Estonia 2003, Poland 2003/2007, Slovak Republic 2008-2009, Turkey 2009-2011, Bosnia 2010, Kosovo 2010) or other international projects (Mednet in 2011, setting up of Israeli Drug and Alcohol Monitoring Centre in 2013).
The Phase II project team at the Observatoire français des drogues et des toxicomanies
Carine Mutatayi, project manager within the Public Policy Evaluation Team, working more specifically on prevention matters related to licit or illicit drugs.
Cristina Diaz Gomez, Head of the Public Policy Evaluation Team, working more specifically on treatment and risk reduction matters.
Key contact for Phase II: Carine Mutatayi was the Phase II project lead within the French partner institution. She has been a Project Manager within the French Monitoring Centre For Drugs and Drug addiction (OFDT) since 1998. Formerly associated with European projects (Phare in 1998, EDDRA management), she joined the Public Policy Evaluation team in 1999 and was appointed to the studies. She is the correspondent to EMCDDA for drug prevention topics related to the French situation. Carine Mutatayi has overseen various evaluation studies on prevention responses in France, for instance, on: local drug prevention policies (1999-2000), drug related training of civil servants (2000-2001), tobacco environmental prevention in secondary schools (2004-2006), experimental gender-specific services for drug-addicted women/mothers (2012-2013). She contributed to the evaluative analyses of the three last French governmental plans (199-2002, 2004-2008, 2008-2011) with a particular insight on prevention policies. From 2006 to 2011, she was responsible for the experimentation of a cross-sector monitoring system on drug prevention actions developed in France.
Role in the Phase II project: A new partner in Phase II, OFDT was most active in the second project year, when it led on the needs assessment and identification of relevant target audiences for the toolkits. OFDT also developed toolkits in collaboration with other partners (EDPQS Toolkit 1 working group).
The organisation: The University Mental Health Research Institute (UMHRI) was founded in 1989. It is a non-profit institute, linked to the University of Athens (Medical School), but administratively and financially independent. UMHRI specialises in conducting and promoting research in the basic sectors of mental health (biological, psychological and social), in offering medical and psychosocial services, as well as in developing training courses on mental health issues.
UMHRI, with its 20 years of expertise, has been at the forefront in the field of drugs and alcohol research and monitoring. Since 1993 UMHRI has been commissioned by the Greek Ministry of Health to operate the Greek REITOX Focal Point of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), while since 1998 the Focal Point has been assigned and operating as the National Documentation and Monitoring Centre for Drugs. In 2001 its activities were expanded in order to serve as a documentation centre for alcohol. The Greek Documentation and Monitoring Centre for Drugs has also participated in several national and European research projects, in EMCDDA projects, as well as in twinning projects of the European Commission.
UMHRI has also been representing Greece since 1995 in the Health Behaviour in the School-aged Children (HBSC) survey, the WHO Collaborative Cross-National Study, and since 1994 in the European School Survey Project on Alcohol & other Drugs (ESPAD).
The Phase II project team at the University Mental Health Research Institute
Key contact for Phase II: Ioulia Bafi is responsible for the Demand Reduction Section of the Greek Documentation and Monitoring Centre for Drugs and Alcohol (EKTEPN), which is also the EMCDDA’s Focal Point and operates under the University Mental Health Research Institute (UMHRI). Ioulia’s main responsibilities in her current position include: monitoring, documentation and reporting of drug demand reduction (prevention, treatment, social rehabilitation) services and programmes implemented at national level, as well as training of professionals on monitoring and data collection. Among her main interests and tasks are the promotion of quality assurance and evaluation in prevention. Ioulia has also been a short-term expert in twinning projects of the EC in the field of drugs and she has participated in national and European projects. Ioulia is a psychologist (BA – University of Essex, MSc – Institute of Education / University of London). Ioulia joined EKTEPN in 2002, while previously she had been involved in training projects for prevention professionals as a member of the scientific staff of the Educational Centre for the Promotion of Health and the Prevention of Drug Abuse (operated under UMHRI). Ioulia is a member of the European Society for Prevention Research (EUSPR).
Anastasios Fotiou is a research associate at the University Mental Health Research Institute (UMHRI) where since 2001 he has been carrying out survey and qualitative research and secondary data analysis on adolescent health and substance use. Currently, he is the deputy principal investigator of ESPAD and HBSC/WHO research projects conducted in Greece by UMHRI. Since 2010, Anastasios has also been Head of the Epidemiology unit at the Greek Documentation & Monitoring Centre for Drugs–Greek REITOX Focal Point. His current research interests include substance use and prevention, non-medical use of prescription medicines, and HIV risks among injecting drug users. Anastasios has (co)authored several scholarly and technical publications in the fields of adolescent substance use, health behaviour, and drug-related harm. Anastasios has a B.A. in sociology from the University of Crete, Greece, an MA in sociology from the Essex University, UK, and completed a Ph.D. in social medicine at Athens University Medical School.
Manina Terzidou is a psychologist, Head of the Greek REITOX Focal Point (EKTEPN) since 2000. Mrs. Terzidou is an expert in the field of drug epidemiology, and has been active in this field since 1984. She has been a member of the staff of the Greek Focal Point since 1993, where she was head of the epidemiology section. She was also a member of the core research group for a number of general population and students drug use national surveys and a member of the ESPAD and the HBSC national research team. She is experienced in national and European project leadership and administration. She was the project leader for Greece in three twinning projects, one in Cyprus, in 2004 and two in Turkey, 2004-2006 and 2009-2011. She also participated as a trainer in the EMCDDA PHARE project for the candidate countries during 2001-2003.
Role in the Phase II project: A new partner in Phase II, UMHRI participated in a number of activities across the project life span. During the first year of the project, UMHRI carried out a case study of a prevention provider in Greece. In the second year, UMHRI assessed the needs of the Greek prevention workforce and, in collaboration with the other partners, developed toolkits for identified target audiences (EDPQS Toolkit 2 working group). At the end of the project, UMHRI facilitated a pilot training workshop to test EDPQS Toolkit 3 and hosted the final project meeting in Athens (see the blog entry).
Eötvös Loránd University, Hungary
The organisation: Eötvös Loránd University, Faculty of Education and Psychology, Institute of Psychology is one of the main institutions of Hungarian psychological education and research. With a growing reputation for research and innovation, Eötvös Loránd University (the longest continuously serving university of Hungary), provides its diverse student population with high quality education and research, building upon the best European traditions. The Institute of Psychology with its 9 Departments and 6 Research groups is involved in approximately 20 large-scale research projects, with more than 50% of these projects being carried out in collaboration with European Universities and Research centres. The research projects cover a wide range of topics from psychophysiology to political psychology including psychogenetics, personality disorders, addiction related problems and the study of social attitudes and cognitive systems.
The Department of Clinical Psychology and Addictions took part in the EDPQS Phase II project. It focuses primarily on addiction research and prevention activities. The mission of the Department is to map the causes and motives of addictions and thereby to support the development of the most effective methods of prevention and treatment to reduce harm related to addictive disorders both at individual and societal levels. Besides epidemiological and etiological research, we focus on studying attitudes toward addicted people as well as on analyzing the effectiveness of preventive and treatment interventions. Beside research activity, our primary goal is disseminating academic knowledge about dependencies. Our main role is diffusing this knowledge in undergraduate, postgraduate and professional education and it is important for us to comprehensively inform lay people as well. Our aim is to help the public think reasonably, on the basis of scientific facts, about an issue surrounded by emotions and passion. The Department of Clinical Psychology and Addiction as part of the Eötvös Loránd University, Institute of Psychology, is a public university department. Beside governmental support the Department is financed from research grants.
The Phase II project team at Eötvös Loránd University
Key contact for Phase II: Katalin Felvinczi, Ph.D. is a social psychologist, deputy director of the Institute of Psychology at the ELTE. She has been involved in the drugs field for over 15 years. Previously she was the director of the National Institute for Drug Prevention. Her main interest is the drug demand reduction related interventions, monitoring and evaluation of prevention interventions. She has a wide range of experiences in planning and managing large-scale projects involving both research and intervention development components. She is member of the chairmanship of the Hungarian Association on Addictions and active in European and international organisations (ISSDP, ICCA).
Role in the Phase II project: Katalin Felvinczi represented Hungary in Phase I as the director of the National Institute for Drug Prevention, and she participated in Phase II as a member of Eötvös Loránd University. In the first project year, Eötvös Loránd University carried out a case study of a targeted prevention programme in Hungary. During the second year, the University assessed professional needs in Hungary and participated in the development of toolkits (lead for EDPQS Toolkit 1). At the end of the project, the University implemented pilot training workshops to test Toolkit 3.
Azienda Sanitaria Locale Milano (ASL Milano), Italy
The organisation: Asl Milano – Azienda Sanitaria Locale di Milano – is the Public Local Health Authority of Milan metropolitan district; it has a public juridical status and its own administrative and organizational autonomy, but depends on the Lombardia Region. Asl is responsible for the management of health-care services and it is structured into several Departments. The Drug Addiction Department, to which our Unit belongs, is in charge of prevention, treatment and social reintegration services.
The Drug Prevention Unit is responsible for planning, coordinating and realizing prevention activities and programmes concerning drug, alcohol (and gambling) abuse. The interventions are implemented in different settings (schools, driving schools, workplaces, youth centres, sports centres, migrants communities) and are based on the “multipliers” strategy: key educational roles and leaders are involved within everyday life to act as prevention multipliers for their target groups. In 2005, the Milan Drug Prevention Unit led a key regional project named “Religo”, aimed to disseminate international evidence based guidelines among drug prevention professionals; to develop a network among regional prevention units; to establish a specific local structure (agency) able to promote and support prevention programmes in line with the local context and in accordance with national and regional strategies and policies. Since its foundation, the Unit had been coordinating the Drug Prevention Regional Network which has the task of developing drug prevention regional programmes, disseminating and promoting research-validated interventions. In these years Milan Drug Prevention Unit has been involved in several international research/intervention projects and has been one of the promoters of the European Drug Prevention Quality Standards (EDPQS) project, as a result of the “Religo” experience.
The Phase II project team at ASL Milano
Key contact for Phase II: Corrado Celata is the Manager of the Milano Drug Prevention Unit and was the project leader for Phase II. He is also in charge of coordinating the Lombardia Regional Drug Prevention network, which gives scientific and technical support to regional policy planning. He is a professional educator, working in ASL Milano since 1994 and always dealing with the fields of drug prevention and health promotion. He has a lot of expertise in planning and coordinating health education and prevention programmes in different settings at a local, regional, national and international level. He works as a supervisor, scientific consultant and teacher for non profit and profit organizations; and has authored/co-authored 20 scientific publications on prevention and health promotion themes.
Nadia Vimercati is a social worker who has been employed by the Milan Drug Prevention Unit since 2001. She has skills and experience in training adult “multipliers” within prevention activities and programmes, especially in the settings of workplaces and driving schools. She coordinates some selective prevention projects/activities at a local level, targeted at risk groups of young drug users. She collaborates with regional/national networks and projects. Involved in international research activities, she participated in Phase I of the European Drug Prevention Quality Standards (EDPQS) project; and in the European project “Pro-skills – for the promotion of social and personal skills in socially unprivileged persons as basic conditions for lifelong learning”. She is a qualified practitioner for using evidence-based drug prevention programmes, such as “Like skills training programme” (Botvin) and the EUDAP-Unplugged programme, both addressed to school settings.
Role in the Phase II project: Already a member in Phase I, ASL Milano was active throughout the entire project. In the first year of Phase II, ASL Milano conducted a case study of an adaptation of the Life Skills Training programme to the Italian context. At the end of the first year, ASL Milano hosted the second Partnership meeting in Milan (see the blog entry). During the second year, ASL Milano took the lead in identifying and reviewing existing toolkits in drug prevention and health promotion, and also conducted an assessment of professional needs in the region. ASL Milano then develop toolkits in collaboration with other partners (lead for EDPQS Toolkit 2) and, towards the end of the project, facilitated a pilot training workshop with University students to test Toolkit 3.
Azienda Sanitaria Locale 2 – Savonese (ASL 2 Savonese), Italy
Web site: http://www.asl2.liguria.it/
The organisation: The Drug Addiction Area, based in the Mental Health and Drug Addiction Department is one of the health territorial Services that form the Local Health Unit, part of the Italian National Health System. Its mission is the prevention of all kinds of addictive behaviours including substance use, treatment and rehabilitation of people with addictive issues. The Addiction Area offers a multi-disciplinary approach to addictions and works with local authorities, hospitals, treatment communities, Municipalities, environmental services and community groups. In the last years many prevention projects have been delivered in the local environment. Collaborations have been realized with the National Health Institute, with the National Department against drugs, with the EMCDDA and the Italian Ministry of health.
The Phase II project team at ASL 2 Savonese
Key contact for Phase II: Dr. Rachele Donini, psychologist, has been working in the Addiction Area of ASL 2 Savonese since 1995. After many years in the clinical field, she has been the head of the Drug Prevention Unit since 2007. Her current work is about prevention project management, team leading and fund raising. She is a drug prevention consultant in the Scientific Board of the National Drug Department, consultant for Liguria region on media education and trainer for teachers and health practitioners. Her interest lies in finding interventions and methodologies that can be more effective and innovative in the drug prevention field.
Role in the Phase II project: Already a member in Phase I, ASL 2 Savonese was most active during the second year of the Phase II project. ASL 2 Savonese assisted with the mapping and review of existing toolkits in drug prevention and health promotion and also carried out a regional assessment of professional needs. This was followed by the development of toolkits in collaboration with the other partners (lead for EDPQS Toolkit 3).
Since completing Phase I, ASL 2 Savonese has been actively disseminating the Standards at a regional level. These activities are described on this web site as examples of using the Standards.
Web site: http://www.mcps.mazovia.pl
The organisation: The Masovian Centre for Social Policy (MCPS) was established on 30 August 1999 by Sejmik of Masovian Province pursuant to Resolution No. XV/66/99. The MCPS is a unit of the provincial government with a status of provincial social policy office. The MCPS works across the whole of Masovian province and is based in Warsaw. The MCPS is a publicly funded agency. In implementing its objectives the MCPS collaborates with the central government, local government, NGOs, legal entities and religious associations. The MCPS’s mission is to reach objectives specified in the Masovian strategy for social policy and achieve socially observable positive results in its crucial points; for instance: substance abuse and domestic violence, poverty, senility, unemployment, disability. The MCPS aims to execute objectives in the areas of social policy allocated by the provincial government, particularly: addressing alcohol dependence related issues, addressing substance abuse issues, preventing domestic violence, assisting disabled individuals and preventing social exclusion. The provincial government is responsible for coordinating, initiating and controlling field units in terms of substance abuse prevention or counteracting domestic violence.
In 2000, the MCPS developed the first provincial drugs strategy 2000-2004. The subsequent 4-year strategies were implemented in 2004-2006 and 2007-2010. The provincial strategies include goals and courses of action included in national drugs strategies. The strategies are developed based on the assessment of drugs and drug addiction in the province of Masovia. Most often these projects are conducted along with the National Bureau for Drug Prevention (an Associate Partner in Phase II of the European Drug Prevention Quality Standards project). The main goal of the current Strategy is the reduction of drug use and the related social and health problems. The specific objectives refer to the three areas: prevention; treatment, rehabilitation, harm reduction, social reintegration; and research and monitoring. An important role in the development of the strategy was played by the Provincial Drug Information Expert, who was responsible for coordinating the strategy activities. The MCPS attaches a lot of importance to systematic improvement of methodological knowledge and skills within professional groups who implements tasks related to substance abuse prevention.
The Addiction Prevention Department implements the Masovian Drugs Strategy and the Masovian Strategy for Preventing and Solving Alcohol-related Problems. The department also develops strategies and programmes. It supervises scientific projects, analyses reports and assessments which later provide grounds for alcohol and drug prevention strategies.
The Phase II project team at the Masovian Centre for Social Policy
Key contact for Phase II: Maria Wrońska is in charge of the Addiction Prevention Department at the Masovian Centre for Social Policy (MCPS). Ms Wrońska holds a medical degree, completed postgraduate administrative law studies and received training in EU funds management. Ms Wronska joined the MCPS in 2000. Since that time she has been involved in substance abuse prevention.
Piotr Oniszk completed pedagogical studies and has been working at the MCPS since 2005.
Role in the Phase II project: As the Polish partner from Phase I could only participate as an Associate Partner in the new project (see below), MCPS was the new Polish Co-beneficiary for Phase II. MCPS was most active during the second project year, assisting with the mapping and review of existing toolkits in drug prevention and health promotion, carrying out an assessment of professional needs, and developing toolkits in collaboration with the other partners (EDPQS Toolkit 1 working group). Towards the end of the project, MCPS also held a pilot training workshop in Poland to test EDPQS Toolkit 3.
Web site: http://www.unodc.org
The organisation: In the area of drug prevention, treatment and care, the UNODC supports Member States in addressing drug use and drug addiction as any other health disorder: i.e. by implementing drug use prevention interventions and providing drug dependence treatment and care services, which are based on scientific evidence and on ethical standards. Another area of work is ensuring access to controlled drugs for medical purposes, whilst preventing diversion and abuse.
The Phase II project team at the UNODC
Key contact for Phase II: Hanna Heikkila
Role in the Phase II project: A new partner in Phase II, the UNODC was following the progress of the project, with a particular focus on potential synergies between this project and the UNODC’s own work in the field of quality assurance in prevention. The UNODC played a key role in disseminating the final project outputs.
The UNODC’s work in quality assurance is also featured on this website’s related projects and activities.
Web site: http://www.goeg.at
The organisation: The Gesundheit Österreich GmbH (GÖG) is a non-profit limited liability company founded in 2006 and the universal successor of the ÖBIG (Austrian Health Institute) which was founded in 1973. The GÖG focuses on research, planning, counselling, training and retraining activities as well as documentation and monitoring in the field of public health. Its work also includes services like the Poison Control Centre or the Early Warning System on New Psychoactive Substances. Many of these tasks are performed on behalf of and in close co-operation with the responsible national administration bodies at the federal and provincial levels. Since 1995, the institution has also been commissioned as the Austrian REITOX Focal Point of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Key contact for Phase II: Marion Weigl
Role in the Phase II project: A new partner in Phase II, GÖG was following the project and providing input and feedback throughout to inform the development of the toolkits and other project materials. As such, their involvement helped to ensure acceptance of the project outputs by relevant peers. They hosted a working group meeting in Vienna (see the blog post) and assisted with the dissemination of the project outputs in Austria.
Web site: http://my-rebound.de
The project: REBOUND is a manualised, school-based drug prevention and health promotion intervention developed at the University of Heidelberg, Germany. The intervention comprises four pillars: classroom-based sessions delivered primarily by teachers, online modules, mentoring and a whole schools approach. The intervention aims to increase life and social skills among adolescents and young adults, with an emphasis on developing resilience and risk competence.
The Phase II project team at REBOUND
Key contact for Phase II: Henrik Jungaberle
Role in the Phase II project: A new partner in Phase II, REBOUND participated as a ‘case’ for the case study activities being undertaken in the first year of the project. This case study was undertaken by LJMU and explored how achievement of the Prevention Standards can be evidenced.
Note: The REBOUND project has now moved to FINDER e.V., web page: https://finder-akademie.de/
Web site: http://www.kbpn.gov.pl/portal?id=75967
The organisation: The goal of the National Bureau for Drug Prevention is the implementation and coordination of national policies on counteracting drug addiction directed at the reduction of narcotic drug and psychotropic substances use.
Key contact for Phase II: Artur Malczewski
Role in the Phase II project: A Co-beneficiary in Phase I, the NBDP was unable to participate again as a Co-beneficiary in Phase II. Their role as an Associate Partner in Phase II, besides following the project and providing feedback on a continuous basis, was to collaborate with the new Polish partner MCPS to ensure that the Phase II activities would build upon the excellent work already undertaken in Poland by the NBDP in Phase I.
Web site: http://www.pnsd.msssi.gob.es/
Key contact for Phase II: Sonia Moncada
Role in the Phase II project: The Spanish partners from Phase I were unable to continue work on Phase II. However, Spanish representation in the project was secured through the participation of the Government Delegation for the Spanish National Plan on Drugs as an Associate Partner. The role of the Government Delegation in Phase II involved providing feedback on the project development to ensure acceptance of the project outputs by relevant peers. Representatives of the Government Delegation also used the materials produced through Phase II to conduct quality assurance activities in Spain (find out more on the Spain country page).
Social Development Unit, Social Services Administration, Stockholm, Sweden
Web site of the Social Development Unit: http://www.stockholm.se/ (in English)
Web site of the Three Cities Project: http://www.stockholm.se/Fristaende-webbplatser/Fackforvaltningssajter/Socialtjanstforvaltningen/Utvecklingsenheten/Prevention/Trestad2/ (in Swedish)
The project: The Three Cities Project was a collaboration between the three largest cities in Sweden (Stockholm, Malmö, Gothenburg) in the area of cannabis prevention between 2012 and 2015. One sub-project within this collaboration focused on quality assurance in prevention, with special consideration of the European Drug Prevention Quality Standards (EDPQS). The lead contact was based in Stockholm, at the Social Development Unit, Social Services Administration, City of Stockholm. Although this sub-project was mainly conducted by partners in Stockholm and Malmö, prevention professionals from all across Sweden were involved as part of a National Reference Group.
The Standards working group within the Three Cities Project
The picture shows the first Three Cities Project meeting focussing on the European Drug Prevention Quality Standards, held in Stockholm, autumn 2012. From left: Prof Mats Berglund, Malmö; Prof Harry Sumnall, LJMU; Kjell Gardeland, Stockholm; Ulf Ljungberg, Malmö; Mats Glans, Malmö; Désirée Söderquist, Stockholm and Anders Eriksson, Stockholm. (click on the image to enlarge)
Role in the Phase II project: A new partner in Phase II, the standards working group of the Three Cities Project formed a ‘case’ for the Partnership’s case study activities in the first project year. It was an exciting opportunity for the Partnership to be studying the work of this group, as the group used the EDPQS to review delivery structures for prevention activities in Sweden. LJMU was responsible for undertaking this case study. The experiences of the Three Cities project informed the development of EDPQS Toolkit 4.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Web site: http://www.emcdda.europa.eu
The organisation: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policy-makers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
Key contact for Phase II: Dr Gregor Burkhart, MD, MPH. Since 1996, Gregor has been responsible for prevention responses at the EMCDDA. He has developed databases on best practice examples (EDDRA), evaluation tools (EIB), the Prevention and Evaluation Resource Kit (PERK) and the Prevention profiles on the EMCDDA’s website. His main activities include the development of common European indicators on the implementation of prevention policies in Member States and the promotion of a better understanding of universal, selective, indicated as well as environmental prevention in Europe. Gregor works on methodologies for monitoring prevention responses as well as how to improve and evaluate them.
Role in the Prevention Standards project: In Phase I, the EMCDDA contributed to the project as an Associate Partner by facilitating collaboration of the Partnership, providing input at all stages of the development process, and funding publication of the final version of Standards in its Manual series. The EMCDDA also funded the production of the Quick Guide to EDPQS including a number of translations. In Phase II, the EMCDDA continued to support the project in an advisory role, through dissemination of relevant information at conferences and in the Best Practice Portal, and fostering collaboration with additional stakeholders, such as COPOLAD.
Page last modified in August 2015.